• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.82% Nasdaq Up2.46%

    Protalix BioTherapeutics, Inc. (PLX)

    -NYSE MKT
    1.45 Down 0.01(0.68%) Sep 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 15,160   11,513   34,424  
    Cost of Revenue9,053  5,428  8,144  
    Gross Profit 6,107   6,085   26,280  
    Operating Expenses
    Research Development21,650  24,816  28,689  
    Selling General and Administrative9,661  8,385  9,763  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (25,204) (27,116) (12,172)
    Income from Continuing Operations
    Total Other Income/Expenses Net196  391  588  
    Earnings Before Interest And Taxes(25,008)(26,725)(11,584)
    Interest Expense4,935  1,065  34  
    Income Before Tax(29,943)(27,790)(11,618)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(29,943)(27,790)(11,618)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (29,943) (27,790) (11,618)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (29,943) (27,790) (11,618)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.